Taiwan News7h
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable ...
The Healthy @Reader's Digest on MSN13h
Can Allergies Make You Cough? Here’s What a Doctor Says
It’s exciting to watch flowers bloom as the weather turns warm, but those spring allergies can be a buzzkill. If you find ...
Onlymyhealth22h
Can Nasal Swab Tests Help Identify Asthma In Children? Here's What You Need To Know
There are certain diagnoses that can be done at home through nasal swab tests but can you detext asthma with that Find out ...